{"address1": "1325 Avenue of Americas", "address2": "28th Floor", "city": "New York", "state": "NY", "zip": "10019", "country": "United States", "phone": "201 488 0460", "website": "https://www.brainstorm-cell.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.", "fullTimeEmployees": 29, "companyOfficers": [{"maxAge": 1, "name": "Mr. Chaim  Lebovits", "age": 53, "title": "President & CEO", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 878783, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Irit  Arbel DSc, Ph.D.", "age": 64, "title": "Co-Founder & Independent Vice Chair of the Board", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alla  Patlis CPA, M.B.A.", "age": 37, "title": "Interim CFO & Controller", "yearBorn": 1987, "fiscalYear": 2023, "totalPay": 130919, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Uri  Yablonka", "age": 47, "title": "Executive VP, Chief Business Officer, Secretary & Director", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 247055, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Hartoun  Hartounian Ph.D.", "age": 64, "title": "Executive VP & COO", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel  Offen Ph.D.", "title": "Chief Scientific Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary Kay Turner", "title": "Senior Vice President of Patient Advocacy & Government Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ibrahim  Dagher M.D.", "age": 55, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Netta  Blondheim-Shraga Ph.D.", "title": "Senior Vice President of Research and Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 3, "compensationRisk": 8, "shareHolderRightsRisk": 2, "overallRisk": 5, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.26, "open": 1.18, "dayLow": 1.17, "dayHigh": 1.2487, "regularMarketPreviousClose": 1.26, "regularMarketOpen": 1.18, "regularMarketDayLow": 1.17, "regularMarketDayHigh": 1.2487, "payoutRatio": 0.0, "beta": 0.738, "forwardPE": -0.48373985, "volume": 28292, "regularMarketVolume": 28292, "averageVolume": 42736, "averageVolume10days": 53130, "averageDailyVolume10Day": 53130, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 6787082, "fiftyTwoWeekLow": 1.05, "fiftyTwoWeekHigh": 11.25, "fiftyDayAverage": 1.6878, "twoHundredDayAverage": 2.96465, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 7859317, "profitMargins": 0.0, "floatShares": 4430878, "sharesOutstanding": 5703430, "sharesShort": 122765, "sharesShortPriorMonth": 110846, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0215, "heldPercentInsiders": 0.20798999, "heldPercentInstitutions": 0.12494001, "shortRatio": 4.54, "shortPercentOfFloat": 0.0227, "impliedSharesOutstanding": 5703430, "bookValue": -1.141, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -14228000, "trailingEps": -3.45, "forwardEps": -2.46, "lastSplitFactor": "1:15", "lastSplitDate": 1727740800, "enterpriseToEbitda": -0.602, "52WeekChange": -0.88502413, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.19, "targetHighPrice": 24.35, "targetLowPrice": 9.0, "targetMeanPrice": 14.45, "targetMedianPrice": 10.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 168000, "totalCashPerShare": 0.029, "ebitda": -13055000, "totalDebt": 841000, "quickRatio": 0.029, "currentRatio": 0.051, "returnOnAssets": -2.15843, "freeCashflow": -6406000, "operatingCashflow": -11330000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCLI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Brainstorm Cell Therapeutics In", "corporateActions": [], "regularMarketTime": 1743537602, "exchange": "NCM", "messageBoardId": "finmb_9048922", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.4978, "fiftyDayAverageChangePercent": -0.29494014, "twoHundredDayAverageChange": -1.7746499, "twoHundredDayAverageChangePercent": -0.5986035, "priceToBook": -1.0429448, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1065533400000, "regularMarketChange": -0.06999993, "regularMarketDayRange": "1.17 - 1.2487", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 42736, "fiftyTwoWeekLowChange": 0.1400001, "fiftyTwoWeekLowChangePercent": 0.13333344, "fiftyTwoWeekRange": "1.05 - 11.25", "fiftyTwoWeekHighChange": -10.059999, "fiftyTwoWeekHighChangePercent": -0.8942222, "fiftyTwoWeekChangePercent": -88.50241, "earningsTimestamp": 1743418809, "earningsTimestampStart": 1747047540, "earningsTimestampEnd": 1747396800, "earningsCallTimestampStart": 1743424200, "earningsCallTimestampEnd": 1743424200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.45, "epsForward": -2.46, "epsCurrentYear": -1.585, "priceEpsCurrentYear": -0.7507887, "longName": "Brainstorm Cell Therapeutics Inc.", "regularMarketChangePercent": -5.5555506, "regularMarketPrice": 1.19, "displayName": "Brainstorm Cell Therapeutics", "trailingPegRatio": null}